Selection of optimal variants of surgical treatment of open arterial duct

  • Yu. V. Panichkin National M. M. Amosov Institute of Cardiovascular Surgery National Academy of Medical Sciences of Ukraine (Kyiv)
  • I. O. Ditkovsky National M. M. Amosov Institute of Cardiovascular Surgery National Academy of Medical Sciences of Ukraine (Kyiv)
  • E. V. Beshlyagha National M. M. Amosov Institute of Cardiovascular Surgery National Academy of Medical Sciences of Ukraine (Kyiv)
  • A. Yu. Gavrilyshyn National M. M. Amosov Institute of Cardiovascular Surgery National Academy of Medical Sciences of Ukraine (Kyiv)
  • Yu. L. Konopleva National M. M. Amosov Institute of Cardiovascular Surgery National Academy of Medical Sciences of Ukraine (Kyiv)
Keywords: Patent Ductus Arteriosus, surgical correction of congenital malformation, transcatheter treatment, occluder

Abstract

The purpose of the work.

The purpose of this work is to compare surgical and endovascular methods of treatment of Patent Ductus Arteriosus (PDA) in order to determine the optimal method of correction.

Materials and methods. The study included 1113 patients who performed a surgical or transcatheter correction of the defect in the interval from 2008 to 2017 on the basis of the GI ICVS named by. М. M. Amosоav NAMS of Ukraine. Surgical operations was performed in 452 patients (40.6%), and transcatheter correction was performed in 661 (59.4%) patients. The choice of the method of correction depended on the age and weight of the patient, the form of the PDA and the presence of concomitant complications.

Results and discussion. Depending on the correction method, the optimal variants of the surgical treatment of the PDA are revealed. Significant differences in the effectiveness between surgical and transcatheter techniques were not detected, however, the number of perioperative complications showed a lower risk of transcatheter technique (1.2% vs. 10.5%), and a decrease in hospital stay (8–10 days for surgical correction up to 3–4 days with transcatheter method).

Conclusions. The transcatheter technique for treating PDA is more secure than surgery, has less complications and is better tolerated by patients. However, despite the apparent advantages of the endovascular method, due to the high cost of devices for the PDA occlusion, further search for ways to improve and reduce the cost of transcatheter treatment for defects is necessary.

References

1. Catheter closure of moderate- to large- new Amplatzer duct occluder: immediate and short-term results / Маsura J., Walsh K. P., Thanopoulous B. et al. // J Am Coll Cardiol. – 1998. – Vol. 31. – P. 878–82.

2. Percutaneous closure of small (<2.5 mm) patent ductus arteriosus using coil embolization / Cambier P. A., Kirby W. C., Wortham D. C. et al. // Am J Cardiol. – 1992. – Vol. 69. – P. 815–6.

3. Transcatheter closure of patent ductus arteriosus with Nit-Occlud coils / Celiker A., Aypar E., Karagoz T. et al. // Catheter Cardiovasc Interv. – 2005. – Vol. 65. – P. 569–76.

4. Gruenstein D. H., Bass J. L. Experimental Аеvaluation of a new articulated Amplatzer ductal occlude device without fabric // Catheter Cardiovascular Interventional. – 2009. – Vol. 74. – P. 482–487.

5. John L. Bass, Neil Wikson. Transcatheter Occkusion of the Patent Ductus Arteriosus in Infants. Experimental Testing of a New Amplatzer Levice // Catheter Cardiovasc Intervtnt. – 2014. – Vol. 83. – P. 250–255.

6. Uemura H. Surgical and catheter procedures in adult congenital heart disease: simple national statistics of the UK tell us something // General thoracic and cardiovascular surgery. – 2013. – Vol. 61 (7). – P. 376–389.

7. Chance of surgery in adult congenital heart disease / Verheugt C. L., Uiterwaal C. S., Vaartjes I. et al. // Eur J Prev Cardiol. – 2017. – Vol. 24 (12). – P. 1319–1327.

8. Warnes C. A. Adult congenital heart disease: the challenges of a lifetime // European heart journal. – 2017. – Vol. 38 (26). – P. 2041–2047.

9. Особенности методики проведения доклинического эксперимента по имплантации окклюдера из бетациркониевого сплава на свиньях как биологической модели / Паничкин Ю. В., Скиба И. О., Захарова В.П. и др. // Серце і судини. – 2015. – № 4 (52). – С. 25–30.

10. Разработка и биологическое апробирование нового спирального окклюдера для эндоваскулярного закрытия артериального протока из низкопрофильного бета-циркониевого сплава // Паничкин Ю. В., Скиба И. О., Захарова В.П. и др. // Серце і судини. – 2017. – № 3 (59). – С. 52–60.
Published
2018-05-14
How to Cite
1.
Panichkin YV, Ditkovsky IO, Beshlyagha EV, Gavrilyshyn AY, Konopleva YL. Selection of optimal variants of surgical treatment of open arterial duct. ujcvs [Internet]. 2018May14 [cited 2024Dec.22];(2 (31):81-5. Available from: https://cvs.org.ua/index.php/ujcvs/article/view/77
Section
CONGENITAL HEART DEFECTS